Cost-effectiveness of diagnostic and therapeutic interventions for chronic hepatitis C: a systematic review of model-based analyses

Cost-effectiveness of diagnostic and therapeutic interventions for chronic hepatitis C: a systematic review of model-based analyses

Abstract Background Decisions about which subgroup of chronic hepatitis C (CHC) patients should be treated with direct acting anti-viral agents (DAAs) have economic importance due to high drug prices. Treat-all DAA strategies for CHC have gained acceptance despite high drug acquisition costs. Howeve...

Full description

Bibliographic Details
Main Authors: Rodolfo Castro, Louise Crathorne, Hugo Perazzo, Julio Silva, Chris Cooper, Jo Varley-Campbell, Daniel Savignon Marinho, Marcela Haasova, Valdilea G. Veloso, Rob Anderson, Chris Hyde
Format: Article
Language:English
Published: BMC 2018-06-01
Series:BMC Medical Research Methodology
Subjects:
Hepatitis C
Cost-effectiveness analysis
Health technology assessment
Online Access:http://link.springer.com/article/10.1186/s12874-018-0515-9

Internet

http://link.springer.com/article/10.1186/s12874-018-0515-9

Similar Items